Pays
Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Danemark108
Claus Christiansen6
Danemark Sauf Claus Christiansen" 104
Claus Christiansen Sauf Danemark" 2
Danemark Et Claus Christiansen 4
Danemark Ou Claus Christiansen 110
Corpus6869
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
001C00 Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Anne Sofie Siebuhr [Danemark] ; Claus Christiansen [Danemark] ; Inger Byrjalsen [Danemark] ; Morten A. Karsdal [Danemark]Early changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study
002455 Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Inger Byrjalsen [Danemark] ; Philippe Vergnoud [France] ; Claus Christiansen [Danemark] ; Morten A. Karsdal [Danemark]Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study.
003962 Morten A. Karsdal [Danemark] ; Thasia Woodworth [États-Unis] ; Kim Henriksen [Danemark] ; Walter P. Maksymowych [Canada] ; Harry Genant [France] ; Philippe Vergnaud [France] ; Claus Christiansen [Danemark] ; Tanja Schubert [France] ; Per Qvist [Danemark] ; Georg Schett [Allemagne] ; Adam Platt [Royaume-Uni] ; Anne-Christine Bay-Jensen [Danemark]Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities
004327 Anne Sofie Siebuhr [Danemark] ; Cecilie F. Kjelgaard-Petersen [Danemark] ; Shu Sun [Danemark] ; Inger Byrjalsen [Danemark] ; Claus Christiansen [Danemark] ; Morten Asser Karsdal [Danemark] ; Anne-Christine Bay-Jensen [Danemark]Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis.
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021